SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
Paper Publishing WeChat
Book Publishing WeChat

Article citations


Hopkins, A.L. and Groom, C.R. (2002) The Druggable Genome. Nature Reviews. Drug Discovery, 1, 727-730.

has been cited by the following article:

  • TITLE: Construction of Enriched Resource for Primary Therapeutic Targets of Approved and Clinical Trial Drugs

    AUTHORS: Hong Yang, Chunyan Yu, Yinghong Li, Feng Zhu

    KEYWORDS: Drug, Drug Target, Indication, Protein Target of a Drug, Target of Disease

    JOURNAL NAME: Journal of Biosciences and Medicines, Vol.5 No.3, March 10, 2017

    ABSTRACT: An assessment of the efficacy targets of drugs that represent an opportunity for targeted therapy is fundamental to the development of post-genomic research strategies within the pharmaceutical industry. Identification and validation of efficacy target is an important process in drug discovery and development. Extensive drug discovery efforts have yielded many approved and candidate drugs. Although sever drug databases provide the drug and their corresponding targets, there is an insufficient coverage of the clinical trial drugs over the past decades. Here, we conduct a comprehensive survey for current clinical trial drugs, therapeutic targets. The analysis contents include: 1) collect clinical trial drugs from different sources, 2) By analysis of the literature, we summarize the criteria for assign therapeutic targets for each drug based on its indication. The knowledge of these drugs and their targets is useful not only for drug discovery and development of targeted therapy, but also for facilitating the discovery of systems pharmacology.